Overview
Updated comprehensive review of the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression
Modern pharmacogenomics of the most important psychotropic drugs such as antipsychotics, antidepressants and mood stabilizers
The attempts to use pharmacogenetics of antipsychotics, antidepressant and mood-stabilizing drugs in practice
Perspectives for future research in pharmacogenetics in major psychoses
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (7 chapters)
-
Front Matter
Keywords
About this book
Written by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. The pharmacogenomics of three categories of the most important psychiatric drugs, antipsychotics, antidepressants and mood stabilizers, has been updated and reviewed.
Some promising directions and perspectives for future research in pharmacogenetics in major psychoses are indicated. They are, among others, connected with the development of new methods in molecular genetics and with linking pharmacogenetics assessment with biomarkers, including neuroimaging ones. Finally, the attempts to use pharmacogenetics of antipsychotic, antidepressant and mood-stabilizing drugs in practice are presented. New pharmacogenetic tools may greatly contribute to introducing personalized medicine into psychiatric clinical practice.
Reviews
“The editors are successful in filling a gap in the literature of research findings about pharmacogenetics as related to psychiatry, as no major book has been published in this area since 2011. Because this is a growing field with great potential, an update is necessary. … psychiatrists or pharmacologists involved in research would get the most from this book. … Each chapter begins with an abstract, has various charts and tables, and concludes with references.” (Aaron Plattner, Doody's Book Reviews, June, 2016)
“The book provides a reader with the full insight into present knowledge of genetic influences on response to drug treatment for major psychiatric disorders such as schizophrenia, bipolar disorder and depression. It helps the reader with better understanding how genetic factors influence psychotropic drug response. … book highlights the benefits of pharmaco-genetics in means of reduced suffering and social economic benefits and it also outlines some new directions for future research. This work contributes significantly to the field of psychiatry.” (Vivian Badžim, Alcoholism and Psychiatry Research, Vol. 52, 2016)
Editors and Affiliations
About the editors
Bibliographic Information
Book Title: Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders
Editors: Janusz K. Rybakowski, Alessandro Serretti
DOI: https://doi.org/10.1007/978-3-319-27040-1
Publisher: Adis Cham
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer International Publishing Switzerland 2016
Hardcover ISBN: 978-3-319-27038-8Published: 17 February 2016
Softcover ISBN: 978-3-319-80061-5Published: 30 March 2018
eBook ISBN: 978-3-319-27040-1Published: 04 February 2016
Edition Number: 1
Number of Pages: IX, 117
Topics: Psychopharmacology, Human Genetics